A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer is a research paper published in Journal of Gastrointestinal Oncology (2022). On theSindex it has a DataRank of 0.976. It has been cited 32 times, with 31 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.524
From this paper's citation signal
Citation Network Contribution
0.451
From 24 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 31 citers.
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
FWCI
1.83
Citation Percentile
0.9%
Influential Citations
3
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals